Restless Leg Syndrome (RLS) Management Protocol
Primary Stack
Core supplements with strongest evidenceIron deficiency strongly linked to RLS; iron essential for dopamine synthesis in brain; supplementation reduces symptoms
Muscle relaxant; supports nervous system function; may reduce RLS symptoms, especially in mild cases
Supporting Stack
Additional supplements for enhanced resultsDeficiency associated with RLS; may affect dopamine pathways; supplementation may reduce severity
Supporting Studies (1)
Supports nerve function; deficiency can cause or worsen RLS symptoms
Supporting Studies (1)
Deficiency can contribute to RLS; important during pregnancy when RLS is common
Supporting Studies (1)
Enhances iron absorption; antioxidant support
Supporting Studies (1)
Antioxidant; some studies suggest benefit for RLS symptoms
Supporting Studies (1)
May improve sleep quality and reduce RLS symptoms through GABA modulation
Supporting Studies (1)
How This Protocol Works
Simple Explanation
Restless Leg Syndrome (RLS), also called Willis-Ekbom Disease, is a neurological condition causing an irresistible urge to move the legs, usually accompanied by uncomfortable sensations (crawling, tingling, pulling, aching). Symptoms typically occur at rest, worsen in the evening/night, and are relieved temporarily by movement. RLS affects 5-10% of adults and significantly disrupts sleep quality.
DIAGNOSTIC CRITERIA (all must be met):
1. Urge to move legs, usually with uncomfortable sensations
2. Symptoms begin or worsen during rest or inactivity
3. Symptoms partially or totally relieved by movement
4. Symptoms worse in evening/night (or only occur then)
5. Not better explained by another condition
FIRST STEPS - CHECK FOR UNDERLYING CAUSES:
LIFESTYLE MEASURES:
* Iron supplementation is the foundation of treatment when ferritin is <75 ng/mL. Even "normal" ferritin levels (15-75) may be inadequate for RLS. Take iron on an empty stomach with vitamin C for best absorption.
* Magnesium may help with muscle relaxation and symptom relief, especially in milder cases.
* Vitamin D deficiency is associated with RLS; supplementation may reduce severity.
* B Vitamins (B12, folate) support nerve function.
WHEN SUPPLEMENTS AREN'T ENOUGH: Prescription medications include dopamine agonists (pramipexole, ropinirole), alpha-2-delta ligands (gabapentin enacarbil, pregabalin), or in severe cases, low-dose opioids. Discuss with a neurologist or sleep specialist.
Expected timeline: Iron supplementation takes 6-12 weeks to show full benefit. Magnesium may help within days to weeks.
Clinical Perspective
Restless Legs Syndrome (Willis-Ekbom Disease): sensorimotor disorder with circadian pattern. Pathophysiology: dopaminergic dysfunction + iron deficiency in substantia nigra (even with normal serum iron); genetic factors (MEIS1, BTBD9 variants). Primary vs Secondary: primary (idiopathic, often familial) vs secondary (iron deficiency, ESRD, pregnancy, neuropathy, medications). Prevalence: 5-10% adults; 2-3% moderate-severe; F>M; increases with age.
CRITICAL: Evaluation - Check ferritin (target ≥75 ng/mL for RLS, not just >15); TSAT; renal function; consider B12, folate, glucose (neuropathy screen); medication review. Treatment algorithm: 1) Treat secondary causes; 2) Non-pharmacological measures; 3) Iron if ferritin <75 (oral or IV); 4) Pharmacotherapy if needed. First-line drugs: alpha-2-delta ligands (gabapentin enacarbil, pregabalin) preferred to avoid augmentation; dopamine agonists (pramipexole, ropinirole, rotigotine patch) effective but risk of augmentation with long-term use. Augmentation: worsening of RLS with dopaminergic therapy - major concern; management requires specialist.
* Iron (A-grade): Essential if ferritin <75. Systematic review: (PMID: 22258033). Clinical guideline: (PMID: 28888875). 65mg elemental iron + vitamin C; empty stomach. IV iron if oral insufficient or not tolerated.
* Magnesium (B-grade): Muscle relaxation; mild cases. Pilot study: (PMID: 9703590). Systematic review: neurological (PMID: 28445426). 300-500mg glycinate/citrate daily.
* Vitamin D (B-grade): Deficiency associated. Meta-analysis: (PMID: 24732735). 2000-4000 IU daily; target >40 ng/mL.
* Vitamin B12 (C-grade): Nerve support. Systematic review: (PMID: 28660890). 1000mcg methylcobalamin daily.
* Folate (C-grade): Pregnancy RLS. Review: (PMID: 28403564). 400-800mcg methylfolate daily.
* Vitamin C (B-grade): Iron absorption. Review: (PMID: 2507689). 200-500mg with iron.
* Vitamin E (C-grade): Antioxidant. Pilot: (PMID: 11888253). 400 IU daily.
* Valerian (C-grade): Sleep; GABA. Clinical trial: (PMID: 19284026). 300-600mg before bed.
Assessment targets: IRLS severity scale, sleep quality (PSQI), ferritin levels, symptom frequency, quality of life.
Protocol notes: Ferritin target: ≥75 ng/mL for RLS (higher than general anemia threshold); recheck at 3-4 months. IV iron: consider if ferritin <75 after oral trial, or ferritin <30 (oral unlikely to work), or intolerance; ferric carboxymaltose 500-1000mg. Iron timing: take on empty stomach; separate from calcium, PPIs, antacids by 2+ hours; vitamin C enhances absorption. Pregnancy RLS: very common (20-30% in 3rd trimester); iron and folate important; usually resolves postpartum; gabapentin considered safe if medications needed. Medication causes: antihistamines (diphenhydramine!), SSRIs/SNRIs, antipsychotics (especially metoclopramide), tramadol - discontinue if possible. Augmentation: worsening/earlier onset of symptoms with dopamine agonists; major reason alpha-2-delta ligands now preferred first-line; if augmentation occurs - taper dopamine agonist slowly, switch to alpha-2-delta. Opioids: low-dose oxycodone or methadone for refractory cases; requires specialist. PLMS: periodic limb movements of sleep - present in 80-90% of RLS; may treat with same medications. Caffeine/alcohol: definite triggers; advise avoidance, especially evening. Exercise: regular moderate exercise helps; avoid intense exercise close to bedtime. Pneumatic compression devices: may help some patients.